Skip to content
menu-icon-lq
close-icon-lq
QA/RA Services
Auditing services

EU MDR and IVDR

Labquality provides medical device manufacturers help with understanding the changing regulations that set the standards of quality and safety of medical devices.

Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (EU MDR) came into force on 26 May 2021, replacing Medical Device Directive 93/42/EEC. 

Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices (EU IVDR) replaced replacing Medical Device Directive 98/79/EC in 2022. However, the transition period of IVDR has been  extended multiple times. 

labquality-frame-green (5)
separator-cyan-thickness2

What are MDR and IVDR?

MDR and IVDR set standards of quality and safety for medical devices to protect the health of patients and users. They set new and stricter requirements for medical devices, their manufacturers, and the Notified Bodies. EU MDR and IVDR cover all devices, reagents and software used for medical purposes.

In addition to commercial manufacturers, certain requirements of the regulations apply also to health institutions’ in-house manufacturing of medical devices.
New obligations to importers, distributors and authorized representatives were introduced, as well.

The conformity assessment procedure of the devices belonging in the risk classes higher than class I (MDR) and class A (IVDR) requires the involvement of a Notified Body.
Due to the new classification rules for the devices, the number of devices requiring assessment by a Notified Body increases significantly, especially for IVD medical devices.

labquality-frame-blue (1)

What requirements do MDR and IVDR bring?

Notified Bodies need to go through an approval process to be qualified for performing conformity assessments under the new regulations.
Now, there is a shortage of approved Notified Bodies for IVDR. Therefore, the European Commission has composed a proposal for an extension of the IVDR go-live dates
for those devices that require an assessment by a Notified Body, length of extension depending on the risk class of the device.

Labquality’s team has wide experience with both MDR and IVDR, covering it all: equipment, reagents as well as software.

Read more about our related trainings

Efficient introduction – Regulatory Essentials in Health Tech – training series >>

Related Services

Qualification and classification of medical devices
Technical documentation
QA/RA Services

Qualification and classification of medical devices

Our team’s versatile experience and the available tools help in bringing clarity to the challenging cases.

Read more
Regulatory plan
Technical documentation
Global Registrations
QA/RA Services

Regulatory plan

Labquality can help medical device manufacturers in creating a regulatory plan.

Read more
Quality Management System ISO 13485
QMS
Auditing services

Quality Management System ISO 13485

Labquality provides medical device manufacturers help with setting up quality management systems (QMS).

Read more
IVDR compliance for in-house developed tests
Technical documentation
QA/RA Services

IVDR compliance for in-house developed tests

Laboratories developing IVDs in-house must maintain Technical Documentation and Quality Management Systems to comply with the IVDR and the national law.

Read more
For Startups, Incubators and Institutions
QA/RA Services

For Startups, Incubators and Institutions

Regulatory compliance is a struggle for Health Tech innovators and startups where ever you go.

Read more
Medical software
Technical documentation
QA/RA Services

Medical software

Labquality also provides comprehensive support for medical software lifecycle.

Read more

Latest news

14/03/24 17:29

Why Modeling Data Flows Is Needed in Clinical Investigations

data management manager explains how data flow modeling will help keep clinical investigation stakeholders informed
Read more
05/03/24 10:37

EQA Coordinator Anna-Riitta Vanhanen Retires After 34 Years of Service

EQA Coordinator Anna-Riitta Vanhanen is retiring in the autumn of 2024 after working at Labquality since 1990. Biochemist Hanna Heikkilä will take over Anna-Riitta's EQA rounds.
Read more
15/02/24 13:08

Read now the new customer reference

Peili Vision has chosen Labquality as the partner for a clinical study to assess the performance and safety of their browser-based, game-like medical software.
Read more
30/11/23 17:00

Mérieux Equity Partners has acquired the majority of Labquality shares

Mérieux Equity Partners (MxEP) acquired a majority stake in Labquality through its Buyout fund, Mérieux Participations 4 (MP4). This investment aims to facilitate industry consolidation and organic expansion in both Contract Research Organization (CRO) and External Quality Assessment (EQA) activities. Cor Group, the Finnish health and wellness services group, continues Labquality's journey, reinvesting alongside MxEP.
Read more
06/11/23 11:31

Meet us at Medica 2023

Labquality’s international sales team will be available for meetings at Medica, the world forum for medicine, held in Düsseldorf on 13-15 November.
Read more

Subscribe to our newsletter

Subscribe to hear the latest news in the industry and keep track of what's happening behind the scenes.